Search results for "Highlights"


 
Results 51 - 60 of about 221 for "Highlights".
Sort by: Relevance | Newest | Oldest

Novel therapy may be effective treatment for H. pylori infection, industry-funded trial finds

About 84% of participants randomly assigned to receive rifabutin in addition to amoxicillin and omeprazole achieved Helicobacter pylori eradication, compared to 58% of those who received amoxicillin and omeprazole alone.
https://gastroenterology.acponline.org/archives/2020/05/22/2.htm
22 May 2020

IV iron regimens compared for serum phosphate effects in patients with IBD

Ferric carboxymaltose and ferric derisomaltose worked well to resolve anemia from inflammatory bowel disease (IBD), but the former was associated with low serum phosphate levels, according to an industry-funded trial.
https://gastroenterology.acponline.org/archives/2022/09/23/2.htm
23 Sep 2022

New practice guidance released for NAFLD

The recommendations from the American Association for the Study of Liver Diseases cover the clinical assessment and management of patients with nonalcoholic fatty liver disease (NAFLD).
https://gastroenterology.acponline.org/archives/2023/03/24/1.htm
24 Mar 2023

Heart failure risk increased in patients with NAFLD, meta-analysis finds

Nonalcoholic fatty liver disease (NAFLD) was associated with a 50% increased risk of new-onset heart failure, independent of age, sex, diabetes, hypertension, and other common cardiovascular risk factors, according to an international meta-analysis.
https://gastroenterology.acponline.org/archives/2022/08/26/2.htm
26 Aug 2022

Practice guidance addresses vascular liver disorders, portal vein thrombosis, procedural bleeding

Among other statements, the American Association for the Study of Liver Diseases said that modifiable risk factors for bleeding, such as use of antithrombotic drugs, should be identified and corrected before procedures in patients with cirrhosis.
https://gastroenterology.acponline.org/archives/2020/12/18/2.htm
18 Dec 2020

DPP-4 inhibitors associated with risk of cholecystitis, meta-analysis finds

Patients with type 2 diabetes who were randomized to receive dipeptidyl peptidase-4 (DPP-4) inhibitors had higher rates of gallbladder disease than those who got placebo or nonincretin drugs, but no difference in risk of cholelithiasis or biliary diseases.
https://gastroenterology.acponline.org/archives/2022/07/22/6.htm
22 Jul 2022

Failure to undergo colonoscopy after positive FIT may double risk for death from colorectal cancer

A retrospective cohort study in Italy compared 10-year cumulative incidence and mortality among patients with a positive result on a fecal immunochemical test (FIT) who completed a diagnostic colonoscopy versus those who did not.
https://gastroenterology.acponline.org/archives/2021/04/23/3.htm
23 Apr 2021

Patient beliefs associated with successful antibiotic treatment of appendicitis

A secondary analysis of a randomized clinical trial found lower risk for appendectomy and higher likelihood of 30-day resolution of signs and symptoms among those who believed that antibiotics could be completely successful versus those who thought they would be unsuccessful or were unsure.
https://gastroenterology.acponline.org/archives/2022/10/28/2.htm
28 Oct 2022

Fatty liver disease may not affect mortality risk in elderly patients

In a Dutch cohort study of patients ages 65 years and older, no association was found between hepatic steatosis and death in the overall population or in clinically relevant subgroups.
https://gastroenterology.acponline.org/archives/2022/07/22/3.htm
22 Jul 2022

Societies issue joint statement on metabolic, bariatric surgery

The American Society for Metabolic and Bariatric Surgery and the International Federation for the Surgery of Obesity and Metabolic Disorders support surgery for patients with a body mass index of 35 kg/m2 or higher regardless of comorbid conditions, among other guidance.
https://gastroenterology.acponline.org/archives/2022/11/18/3.htm
18 Nov 2022

Result Page: Prev   1   2   3   4   5   6   7   8   9   10   Next